Intellia Therapeutics to Present at November Investor Healthcare Conferences

CAMBRIDGE, Mass., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on the development of potentially curative therapeutics using CRISPR/Cas9 technology, announced that senior company leaders will present at key November investor healthcare conferences, including the 25th Annual Credit Suisse Healthcare Conference and the Jefferies 2016 London Healthcare Conference.

Details of the upcoming presentations are as follows:

Monday, November 7th

25th Annual Credit Suisse Healthcare Conference, 2016

Location: Scottsdale, Arizona

Presentation Time: 11:30 AM MST

Thursday, November 17th

Jefferies 2016 London Healthcare Conference

Location: London, England

Presentation Time: 3:20 PM GMT

Individuals may access the presentations for each conference via live webcast on the Intellia website at www.intelliatx.com under "Events & Presentations" in the "Investor Relations" section. A replay of the webcast will be available on this site for 90 days following the live event.

About Intellia Therapeutics

Jennifer Mound Smoter

Chief External Affairs & Communications Officer

With a Reader Account, it's easy to send email directly to the contact for this release. Sign up today for your free Reader Account!

Already have an account? Log in here.